Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Magnani

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Chemical Information and Modeling|October 24, 2008
Targets looking for drugs: a multistep computational protocol for the development of structure-based pharmacophores and their applications for hit discoveryCristina Tintori, Valentina Corradi, Matteo Magnani, et al.
The FEBS Journal|May 23, 2009
Possible binding site for paclitaxel at microtubule poresMatteo Magnani, Giorgio Maccari, José M Andreu, et al.
The FEBS Journal|June 29, 2006
The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics studiesMatteo Magnani, Francesco Ortuso, Simonetta Soro, et al.
Journal of Chemical Information and Modeling|May 23, 2006
A genetic-function-approximation-based QSAR model for the affinity of arylpiperazines toward alpha1 adrenoceptorsLaura Maccari, Matteo Magnani, Giovannella Strappaghetti, et al.
Scientific Reports|August 19, 2025
Anatomy of a Swedish population-scale networkGeorgios Panayiotou, Inga K Wohlert, Miia Bask, et al.
Journal of Chemical Information and Modeling|August 24, 2010
Molecular interaction fields and 3D-QSAR studies of p53-MDM2 inhibitors suggest additional features of ligand-target interactionCristina Dezi, Andrea Carotti, Matteo Magnani, et al.
Chemmedchem|August 8, 2006
Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of mycobacterium tuberculosisFabrizio Manetti, Matteo Magnani, Daniele Castagnolo, et al.
Chemmedchem|February 14, 2007
Inhibition of Bcr-Abl phosphorylation and induction of apoptosis by pyrazolo[3,4-d]pyrimidines in human leukemia cellsFabrizio Manetti, Annalisa Pucci, Matteo Magnani, et al.
Bioorganic & Medicinal Chemistry|August 30, 2008
Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosisDaniele Castagnolo, Alessandro De Logu, Marco Radi, et al.
Journal of Medicinal Chemistry|February 9, 2008
Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell linesFabrizio Manetti, Chiara Brullo, Matteo Magnani, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Chemical Information and Modeling|October 24, 2008
Targets looking for drugs: a multistep computational protocol for the development of structure-based pharmacophores and their applications for hit discoveryCristina Tintori, Valentina Corradi, Matteo Magnani, et al.
The FEBS Journal|May 23, 2009
Possible binding site for paclitaxel at microtubule poresMatteo Magnani, Giorgio Maccari, José M Andreu, et al.
The FEBS Journal|June 29, 2006
The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics studiesMatteo Magnani, Francesco Ortuso, Simonetta Soro, et al.
Journal of Chemical Information and Modeling|May 23, 2006
A genetic-function-approximation-based QSAR model for the affinity of arylpiperazines toward alpha1 adrenoceptorsLaura Maccari, Matteo Magnani, Giovannella Strappaghetti, et al.
Scientific Reports|August 19, 2025
Anatomy of a Swedish population-scale networkGeorgios Panayiotou, Inga K Wohlert, Miia Bask, et al.
Journal of Chemical Information and Modeling|August 24, 2010
Molecular interaction fields and 3D-QSAR studies of p53-MDM2 inhibitors suggest additional features of ligand-target interactionCristina Dezi, Andrea Carotti, Matteo Magnani, et al.
Chemmedchem|August 8, 2006
Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of mycobacterium tuberculosisFabrizio Manetti, Matteo Magnani, Daniele Castagnolo, et al.
Chemmedchem|February 14, 2007
Inhibition of Bcr-Abl phosphorylation and induction of apoptosis by pyrazolo[3,4-d]pyrimidines in human leukemia cellsFabrizio Manetti, Annalisa Pucci, Matteo Magnani, et al.
Bioorganic & Medicinal Chemistry|August 30, 2008
Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosisDaniele Castagnolo, Alessandro De Logu, Marco Radi, et al.
Journal of Medicinal Chemistry|February 9, 2008
Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell linesFabrizio Manetti, Chiara Brullo, Matteo Magnani, et al.
Pageof 3